Sanofi (SNY) — Analyst outlook / Analyst consensus target is. Based on 27 analyst ratings, the consensus is bullish — 14 Buy, 11 Hold, 2 Sell.
The consensus price target is $57.02 (low: $48.07, high: $64.00), representing an upside of 19.7% from the current price $47.64.
Analysts estimate Earnings Per Share (EPS) of $3.69 and revenue of $43.95B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $2.30 vs est $3.69 (missed -37.7%). 2025: actual $2.03 vs est $3.86 (missed -47.4%). Analyst accuracy: 25%.
SNY Stock — 12-Month Price Forecast
$57.02
▲ +19.69% Upside
Average Price Target
Based on 27 Wall Street analysts offering 12-month price targets for Sanofi, the average price target is $57.02, with a high forecast of $64.00, and a low forecast of $48.07.
The average price target represents a +19.69% change from the last price of $47.64.
Highest Price Target
$64.00
Average Price Target
$57.02
Lowest Price Target
$48.07
SNY Analyst Ratings
Buy
Based on 27 analysts giving stock ratings to Sanofi in the past 3 months
EPS Estimates — SNY
25%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $2.30
vs Est $3.69
▼ 60.4% off
2025
Actual $2.03
vs Est $3.86
▼ 90.1% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is declining. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — SNY
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $44.286B
vs Est $43.948B
▲ 0.8% off
2025
Actual $46.716B
vs Est $45.140B
▲ 3.4% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
